Brief: Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function And Macular Carotenoid Changes
28/10/2020 12:34
Oct 28 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES ANNOUNCES NEWLY-PUBLISHED
DATA DEMONSTRATING SUPERIOR VISUAL FUNCTION AND MACULAR
CAROTENOID CHANGES USING GUARDION’S PROPRIETARY LUMEGA-Z®
FORMULATION COMPARED TO AREDS-2 FORMULATION
* GUARDION HEALTH SCIENCES INC - STUDY COMPARED EFFICACY OF
LUMEGA-Z TO CURRENT STANDARD OF CARE, AREDS-2 SOFT GEL
SUPPLEMENT
Source text for Eikon: ID:nGNX4vlXxq
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview